Benatti Luca
- SEC CIK
- 0001613842
In the past year, 1 open-market sale filing worth $173.5K and no purchases.
Current role at each company
- QNCX Quince Therapeutics, Inc.Directoras of Dec 29, 2025
- ICPT Intercept Pharmaceuticals, Inc.Directoras of Nov 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $173.5K
- 1 filing
- Net
- −$173.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Benatti Luca as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QNCX Quince Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 (view filing) | Dec 26 | 3 days | Benatti LucaDirector | SSale | −50.0K | $3.47 | −$173.5K | −56.1%39.2K after |